FERRANTE, MARICA
 Distribuzione geografica
Continente #
NA - Nord America 188
EU - Europa 174
AS - Asia 94
AF - Africa 2
SA - Sud America 2
Totale 460
Nazione #
US - Stati Uniti d'America 186
SE - Svezia 67
IT - Italia 55
CN - Cina 41
SG - Singapore 38
FI - Finlandia 15
RU - Federazione Russa 15
DE - Germania 9
GB - Regno Unito 6
IN - India 5
PH - Filippine 4
IR - Iran 3
BE - Belgio 2
CA - Canada 2
ID - Indonesia 2
IE - Irlanda 2
LT - Lituania 2
PE - Perù 2
TN - Tunisia 2
NL - Olanda 1
TH - Thailandia 1
Totale 460
Città #
Ashburn 41
Singapore 27
New York 24
Shanghai 18
Boardman 17
Helsinki 14
Lawrence 14
Princeton 14
Milan 11
Washington 8
Moscow 7
Pune 5
Vittoria 5
Dallas 4
London 4
Quezon City 4
Seattle 4
Angera 3
Borås 3
Brookings 3
Ahvaz 2
Bandung 2
Brussels 2
Dublin 2
Falkenstein 2
Guangzhou 2
Padova 2
Rome 2
Segrate 2
Torre Del Greco 2
Verona 2
Amsterdam 1
Baoding 1
Cesano Maderno 1
Hangzhou 1
Jiaxing 1
Kassel 1
Lainate 1
Lappeenranta 1
Los Angeles 1
Nanjing 1
Nuremberg 1
Ottawa 1
Paliano 1
Pavia 1
Pisa 1
Quanzhou 1
San Sperate 1
Stockholm 1
Taizhou 1
Toronto 1
Weitang 1
Wuxi 1
Xi'an 1
Yangzhou 1
Totale 276
Nome #
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 51
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 43
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 34
Residual lung damage following ARDS in COVID-19 ICU survivors 34
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 33
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 30
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 28
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 28
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 27
Impact of the environment on the health: From theory to practice 27
One-year mental health outcomes in a cohort of COVID-19 survivors 27
Weight trajectories and abdominal adiposity in COVID-19 survivors with overweight/obesity 21
Pesticidi e rischio di sclerosi laterale amiotrofica: il contributo della metodologia GIS in uno studio in Emilia Romagna e in Sicilia. 20
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX 18
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease 17
Micronized/ultramicronized palmitoylethanolamide improves depression and fatigue in coronavirus disease 2019 (COVID-19) survivors 15
Myosteatosis Significantly Predicts Persistent Dyspnea and Mobility Problems in COVID-19 Survivors 14
Mismatch repair deficiency as prognostic factor for stage III small bowel adenocarcinoma: A multicentric international study 11
UNINTENTIONAL WEIGHT LOSS IN COVID-19 SURVIVORS FROM THE FIRST AND THE SECOND PANDEMIC WAVES 7
GLUCOCORTICOID TREATMENT IN PATIENTS WITH COVID-19 PNEUMONIA: DIFFERENCES BETWEEN COVID-19 SURVIVORS AND NON-SURVIVORS 4
HEALTH STATUS OF COVID-19 SURVIVORS: A COMPARISON BETWEEN THE FIRST AND THE SECOND PANDEMIC WAVE 4
NEW-ONSET HYPERGLYCAEMIA IN NON DIABETIC PATIENTS DURING SARS-COV-2 HOSPITALIZATION: PREVALENCE AND RISK FACTORS 4
European evidence based consensus for endoscopy in inflammatory bowel disease 3
Totale 500
Categoria #
all - tutte 5.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.476


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 1 0 5 1 1 1 0 1 0
2021/202246 1 0 0 5 0 7 6 5 7 3 8 4
2022/2023119 35 27 7 4 7 12 4 14 4 0 2 3
2023/2024226 14 14 39 16 24 51 2 20 0 4 6 36
2024/202599 18 14 7 14 38 8 0 0 0 0 0 0
Totale 500